Usana Health Sciences (USNA) Total Current Liabilities (2011 - 2026)

Usana Health Sciences (USNA) has reported Total Current Liabilities for 16 consecutive years, with $105.7 million the latest figure, recorded in Q3 2026.

• On a quarterly basis, Total Current Liabilities fell 13.11% year-over-year to $105.7 million in Q3 2026; TTM through Jul 2026 was $105.7 million, a 13.11% decrease from a year earlier, with the FY2026 full-year figure at $128.6 million, down 7.92% from the prior year.
• Total Current Liabilities was $105.7 million for Q3 2026 at Usana Health Sciences, down from $117.2 million in the prior quarter.
• Over five years, Total Current Liabilities peaked at $160.8 million in Q1 2022 and troughed at $103.9 million in Q2 2024.
• A 5-year average of $126.2 million and a median of $121.6 million in 2025 frame the typical range for Total Current Liabilities.
• Across the five-year window, Total Current Liabilities slipped 20.33% in 2022 and grew 21.98% in 2025, its largest moves.
• Over 5 years, Total Current Liabilities stood at $143.8 million in 2022, then declined by 17.37% to $118.8 million in 2023, then climbed by 17.48% to $139.6 million in 2024, then declined by 15.01% to $118.7 million in 2025, then slipped by 10.95% to $105.7 million in 2026.
• The last three Total Current Liabilities figures came in at $105.7 million (Q3 2026), $117.2 million (Q2 2026), and $128.6 million (Q1 2026), per Business Quant data.